Lentz SS - Search Results

1

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study.

Ball HG, Blessing JA, Lentz SS, Mutch DG. Ball HG, et al. Among authors: lentz ss. Gynecol Oncol. 1996 Aug;62(2):278-81. doi: 10.1006/gyno.1996.0227. Gynecol Oncol. 1996. PMID: 8751561 Clinical Trial.

2

A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a gynecologic oncology group study.

Miller DS, Blessing JA, Lentz SS, Waggoner SE. Miller DS, et al. Among authors: lentz ss. Gynecol Oncol. 2002 Dec;87(3):247-51. doi: 10.1006/gyno.2002.6804. Gynecol Oncol. 2002. PMID: 12468321 Clinical Trial.

3

A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.

Hoffman MA, Blessing JA, Lentz SS; Gynecologic Oncology Group Study. Hoffman MA, et al. Among authors: lentz ss. Gynecol Oncol. 2003 Apr;89(1):95-8. doi: 10.1016/s0090-8258(03)00007-6. Gynecol Oncol. 2003. PMID: 12694660 Clinical Trial.

4

Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study.

Thigpen JT, Blessing JA, Olt G, Lentz SS, Bell J. Thigpen JT, et al. Among authors: lentz ss. Gynecol Oncol. 2003 Sep;90(3):581-6. doi: 10.1016/s0090-8258(03)00327-5. Gynecol Oncol. 2003. PMID: 13678728 Clinical Trial.

5

Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: a gynecologic oncology group study.

Miller DS, Blessing JA, Lentz SS, McMeekin DS. Miller DS, et al. Among authors: lentz ss. Cancer. 2003 Oct 15;98(8):1664-9. doi: 10.1002/cncr.11690. Cancer. 2003. PMID: 14534883 Free article. Clinical Trial.

6

A phase II trial of 5-fluorouracil and high-dose leucovorin in patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Look KY, Blessing JA, Gallup DG, Lentz SS. Look KY, et al. Among authors: lentz ss. Am J Clin Oncol. 1996 Oct;19(5):439-41. doi: 10.1097/00000421-199610000-00002. Am J Clin Oncol. 1996. PMID: 8823469 Clinical Trial.

7

Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.

Lincoln S, Blessing JA, McGehee R, Lentz SS. Lincoln S, et al. Among authors: lentz ss. Am J Clin Oncol. 1997 Feb;20(1):84-5. doi: 10.1097/00000421-199702000-00019. Am J Clin Oncol. 1997. PMID: 9020296 Clinical Trial.

8

Altretamine (hexamethylmelamine) in platinum-resistant and platinum-refractory ovarian cancer: a Gynecologic Oncology Group phase II trial.

Markman M, Blessing JA, Moore D, Ball H, Lentz SS. Markman M, et al. Among authors: lentz ss. Gynecol Oncol. 1998 Jun;69(3):226-9. doi: 10.1006/gyno.1998.5016. Gynecol Oncol. 1998. PMID: 9648592 Clinical Trial.

9

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

McGuire WP, Blessing JA, Moore D, Lentz SS, Photopulos G. McGuire WP, et al. Among authors: lentz ss. J Clin Oncol. 1996 Mar;14(3):792-5. doi: 10.1200/JCO.1996.14.3.792. J Clin Oncol. 1996. PMID: 8622025 Clinical Trial.

10

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q).

Herzog TJ, Sill MW, Walker JL, O'Malley D, Shahin M, DeGeest K, Weiner SA, Mutch D, DeBernardo RL, Lentz SS. Herzog TJ, et al. Among authors: lentz ss. Gynecol Oncol. 2011 Mar;120(3):454-8. doi: 10.1016/j.ygyno.2010.11.008. Epub 2010 Dec 17. Gynecol Oncol. 2011. PMID: 21168198 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page